SCHEMBL8525317

SCHEMBL8525317

C=CCN(CC=C)c1cc(C=CC=O)ccc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.39
CCNB2 O95067 3/20 0.36
CDK1 P06493 3/20 0.36
CDK4 P11802 3/20 0.36
CCNB1 P14635 3/20 0.36
CCND1 P24385 3/20 0.36
CCNB3 Q8WWL7 3/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 1/20 0.35
TRPA1 O75762 2/20 0.34
MTNR1A P48039 1/20 0.34
LMNA P02545 2/20 0.33
ALOX5 P09917 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
MMP2 P08253 1/20 0.32
GAA P10253 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9449080 0.74 ALDH1A1 (0.46) XDHCCNB2CDK1CDK4CCNB1
SCHEMBL1688845 0.74 C5AR1 (0.38) ALDH1A1KDM4ELMNASMN1; SMN2GAA
SCHEMBL11195337 0.71 XDH (0.53) XDHCCNB2CDK1CDK4CCNB1
SCHEMBL14674909 0.71 XDH (0.53) XDHCCNB2CDK1CDK4CCNB1
SCHEMBL10583374 0.69 CDK4 (0.44) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL8525313 0.69 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTLMNAMAPK1
SCHEMBL18255202 0.67 XDH (0.48) XDHCCNB2CDK1CDK4CCNB1
SCHEMBL14087957 0.67 XDH (0.69) XDHCCNB2CDK1CDK4CCNB1
SCHEMBL14145570 0.67 MAOB (0.44) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL544101 0.67 C5AR1 (0.44) ALDH1A1LMNAALOX5CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977075-A N-aroylamino acid amides as endothelin inhibitors NOVARTIS AG (CH) 1999-11-02 US disclosed
EP-0821670-A1 N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS Novartis AG (CH) 1998-02-04 EP disclosed
WO-1996033170-A1 N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS NOVARITS AG (CH) 1996-10-24 WO disclosed